INS and diabetes mellitus: Limitations of the trial include the potential for unblinding of research nurses undertaking follow-up measurements to allocated group and the inability to identify whether the intervention may be more effective in patient sub-groups, for example people with newly diagnosed diabetes or who may shortly require insulin treatment.